Skip to main content

Table 2 Comparison of screening markers in the PCOS and control groups

From: Effect of maternal polycystic ovary syndrome (PCOS) on screening of aneuploidy in the first and second trimesters

Variables

PCOS (n = 90)

Control (n = 90)

P-value

NT (mm)*

1.6 ± 0.38

1.41 ± 0.36

0.37

Free β-HCG (ng/ml)*

34.42 ± 18.92

28.99 ± 18.80

0.04

PAPP-A (mu/ml)*

4903.80 ± 8571.87

2994.93 ± 1626.76

0.59

AFP (ng/ml)**

38.34 ± 15.91

32.14 ± 15.13

0.02

HCG (mu/ml)*

19496.31 ± 16694.98

177199.21 ± 18877.56

0.11

UE3 (ng/ml)*

2.3 ± 1.89

2.01 ± 1.12

0.45

Inhibin-A (pg/ml)*

276.14 ± 129.38

223.44 ± 102.07

0.001

  1. PCOS: Polycystic Ovary Syndrome, NT: Nuchal Translucency, Free β-HCG: Free Beta-Human Chorionic Gonadotropin, PAPP-A: Plasma Protein A, AFP: Alpha Fetoprotein, HCG: Human Chorionic Gonadotropin, UE3: Unconjugated Estriol
  2. *Values are given as mean ± SD using Mann-Whitney’s U test
  3. **Values are given as mean ± SD using students T-test
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us